ReviewAnnals of neurology2023
Trials for Slowly Progressive Neurogenetic Diseases Need Surrogate Endpoints.
Mary M Reilly et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it
ReviewAnnals of neurology2023
Mary M Reilly et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.